Accretion Nutraveda IPO

Schedule of Accretion Nutraveda

Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.

About Accretion Nutraveda

Incorporated in 2021 as Accretion Nutraveda Private Limited and converted into a public limited company in 2025, Accretion Nutraveda Limited operates as a healthcare-focused Contract Development and Manufacturing Organization. The company manufactures Ayurvedic and nutraceutical products across multiple dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations. It serves domestic clients and export markets such as Sri Lanka, Singapore, and the USA, combining classical Ayurvedic knowledge with modern nutraceutical science to deliver customized manufacturing solutions.

The company operates from a GMP and WHO-GMP certified leased manufacturing facility in Gujarat, equipped with advanced infrastructure and multiple quality certifications. Its business model is primarily driven by contract manufacturing through domestic sales, merchant exports, and direct exports. Led by an experienced promoter-led board and supported by established customer and supplier relationships, the company has demonstrated strong revenue and profitability growth. Its diversified product portfolio, quality compliance, and focus on long-term partnerships position it well in the growing Ayurvedic and nutraceutical manufacturing space.